Profile of patients using hydroquinone in treatment of melasma
International Journal of Development Research
Profile of patients using hydroquinone in treatment of melasma
Received 17th August, 2019; Received in revised form 26th September, 2019; Accepted 19th October, 2019; Published online 30th November, 2019
Copyright © 2019, Daniela Pereira de Almeida Ruas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article presents the interest in studying about the use of hydroquinone for the treatment of melasma by patients with hyperpigmentation as a cutaneous alteration, characterizing the profile of these patients, and to verify their knowledge about the risks caused by indiscriminate use. This drug also describes the main risks of using hydroquinone without medical and pharmaceutical guidance, pointing out the importance of the pharmaceutical professional during the dispensing of hydroquinone. This is a descriptive, cross-sectional research with a quantitative approach, conducted in a community pharmacy in the city of Belo Campo.
